U.S. Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report By Raw Material (Polyester, Polytetrafluoroethylene), By Region (West, Midwest), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. Hemodialysis Vascular Grafts Market Growth & Trends
The U.S. hemodialysis vascular grafts market size is anticipated to reach USD 68.5 million by 2030, growing at a CAGR of 4.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the primary drivers of the market is the rising prevalence of end-stage renal disease (ESRD). ESRD is a significant public health concern, with a growing number of patients requiring hemodialysis as a life-sustaining treatment. This increasing patient population drives the demand for hemodialysis vascular grafts to create reliable access to dialysis procedures.
There is a noticeable trend towards minimally invasive procedures in the field of vascular access for hemodialysis. Minimally invasive techniques reduce patient discomfort, recovery time, and complications associated with traditional surgical interventions. As a result, healthcare providers are increasingly adopting hemodialysis vascular grafts that support minimally invasive approaches, driving market growth.
In April 2023, the Aspirex mechanical suction thrombectomy system, which employs 6- and 8-F catheters, was approved by the FDA under 510(k) for use by BD (Becton, Dickinson, and Company) to remove acute emboli and clots for hemodialysis access to arteriovenous grafts and native arteriovenous fistulas. This device was introduced in 2022 and operates on a three-pronged mechanism mechanical transportation for effective clot removal through the catheter and out of the channel, continuous clot maceration to prevent clogging, and enhanced clot aspiration.
U.S. Hemodialysis Vascular Grafts Market Report Highlights
U.S. Hemodialysis Vascular Grafts Market Growth & Trends
The U.S. hemodialysis vascular grafts market size is anticipated to reach USD 68.5 million by 2030, growing at a CAGR of 4.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the primary drivers of the market is the rising prevalence of end-stage renal disease (ESRD). ESRD is a significant public health concern, with a growing number of patients requiring hemodialysis as a life-sustaining treatment. This increasing patient population drives the demand for hemodialysis vascular grafts to create reliable access to dialysis procedures.
There is a noticeable trend towards minimally invasive procedures in the field of vascular access for hemodialysis. Minimally invasive techniques reduce patient discomfort, recovery time, and complications associated with traditional surgical interventions. As a result, healthcare providers are increasingly adopting hemodialysis vascular grafts that support minimally invasive approaches, driving market growth.
In April 2023, the Aspirex mechanical suction thrombectomy system, which employs 6- and 8-F catheters, was approved by the FDA under 510(k) for use by BD (Becton, Dickinson, and Company) to remove acute emboli and clots for hemodialysis access to arteriovenous grafts and native arteriovenous fistulas. This device was introduced in 2022 and operates on a three-pronged mechanism mechanical transportation for effective clot removal through the catheter and out of the channel, continuous clot maceration to prevent clogging, and enhanced clot aspiration.
U.S. Hemodialysis Vascular Grafts Market Report Highlights
- As the population ages and the prevalence of conditions such as diabetes and hypertension increases, more individuals require hemodialysis, driving the market for vascular grafts.
- The polytetrafluoroethylene raw material segment dominated the market with a share of around 45.5% in 2023 and is anticipated to witness the fastest CAGR during the forecast period. This is attributed to the benefits associated with the material such as ease of handling, durability, and resistance to infection.
- In June 2023, Merit Medical System Inc. acquired a catheter system from Bluegrass Vascular for USD 32.5 million followed with a larger USD 100 million asset purchase from AngioDynamics.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Raw Material
1.2.2. Regional scope
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Raw material outlook
2.3. Competitive Insights
CHAPTER 3. U.S. HEMODIALYSIS VASCULAR GRAFTS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. Hemodialysis Vascular Grafts Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. HEMODIALYSIS VASCULAR GRAFTS MARKET: RAW MATERIAL ESTIMATES & TREND ANALYSIS
4.1. Raw Material Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Hemodialysis Vascular Grafts Market by Raw Material Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Polyester
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Polytetrafluoroethylene
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Polyurethane
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Biological Materials
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.2. Human Saphenous & Umbilical Veins
4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.3. Tissue Engineered Materials
4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. U.S. HEMODIALYSIS VASCULAR GRAFTS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
5.1. Regional Market Share Analysis, 2023 & 2030
5.2. U.S. Hemodialysis Vascular Grafts Market by Region Outlook
5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
5.3.1. West
5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.2. Midwest
5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3. Northeast
5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.4. Southwest
5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.5. Southeast
5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company heat map analysis, 2023
6.4. Company Profiles
6.4.1. Getinge
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. Medtronic
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. W. L. Gore & Associates
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. LeMaitre
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. CryoLife
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Merit Medical Systems
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. C.R. Bard, Inc.
6.4.7.1. Company overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. Vascudyne, Inc.
6.4.8.1. Company overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Raw Material
1.2.2. Regional scope
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Raw material outlook
2.3. Competitive Insights
CHAPTER 3. U.S. HEMODIALYSIS VASCULAR GRAFTS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. Hemodialysis Vascular Grafts Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. HEMODIALYSIS VASCULAR GRAFTS MARKET: RAW MATERIAL ESTIMATES & TREND ANALYSIS
4.1. Raw Material Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Hemodialysis Vascular Grafts Market by Raw Material Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Polyester
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Polytetrafluoroethylene
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Polyurethane
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Biological Materials
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.2. Human Saphenous & Umbilical Veins
4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.3. Tissue Engineered Materials
4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. U.S. HEMODIALYSIS VASCULAR GRAFTS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
5.1. Regional Market Share Analysis, 2023 & 2030
5.2. U.S. Hemodialysis Vascular Grafts Market by Region Outlook
5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
5.3.1. West
5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.2. Midwest
5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3. Northeast
5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.4. Southwest
5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.5. Southeast
5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company heat map analysis, 2023
6.4. Company Profiles
6.4.1. Getinge
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. Medtronic
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. W. L. Gore & Associates
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. LeMaitre
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. CryoLife
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Merit Medical Systems
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. C.R. Bard, Inc.
6.4.7.1. Company overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. Vascudyne, Inc.
6.4.8.1. Company overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 U.S. hemodialysis vascular grafts market, by raw material, 2018 - 2030 (USD Million)
Table 3 U.S. hemodialysis vascular grafts market, by region, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 U.S. hemodialysis vascular grafts market, by raw material, 2018 - 2030 (USD Million)
Table 3 U.S. hemodialysis vascular grafts market, by region, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. hemodialysis vascular grafts market: Market outlook
Fig. 9 U.S. hemodialysis vascular grafts competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. hemodialysis vascular grafts market driver impact
Fig. 14 U.S. hemodialysis vascular grafts market restraint impact
Fig. 15 U.S. hemodialysis vascular grafts market: Raw material movement analysis
Fig. 16 U.S. hemodialysis vascular grafts market: Raw material outlook and key takeaways
Fig. 17 Polyester market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Polytetrafluoroethylene market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Polyurethane market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Biological materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Human saphenous & umbilical veins market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 22 Tissue engineered materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 U.S. hemodialysis vascular grafts market: Regional movement analysis
Fig. 24 U.S. hemodialysis vascular grafts market: Regional outlook and key takeaways
Fig. 25 West market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. hemodialysis vascular grafts market: Market outlook
Fig. 9 U.S. hemodialysis vascular grafts competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. hemodialysis vascular grafts market driver impact
Fig. 14 U.S. hemodialysis vascular grafts market restraint impact
Fig. 15 U.S. hemodialysis vascular grafts market: Raw material movement analysis
Fig. 16 U.S. hemodialysis vascular grafts market: Raw material outlook and key takeaways
Fig. 17 Polyester market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Polytetrafluoroethylene market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Polyurethane market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Biological materials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Human saphenous & umbilical veins market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 22 Tissue engineered materials market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 U.S. hemodialysis vascular grafts market: Regional movement analysis
Fig. 24 U.S. hemodialysis vascular grafts market: Regional outlook and key takeaways
Fig. 25 West market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)
